• 1. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 2. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 3. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 4. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 5. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin

• Solvents and Organic Chemicals Organic Compounds Organic 1,3-dipolar compounds Allyl-type 1,3-dipolar organic compounds C-nitro compounds
• Solvents and Organic Chemicals Organic Compounds Organic 1,3-dipolar compounds Allyl-type 1,3-dipolar organic compounds Organic nitro compounds C-nitro compounds

Introduction to 3,4-Dimethyl-5-nitropyridine (CAS No: 65169-36-0)

3,4-Dimethyl-5-nitropyridine, identified by its Chemical Abstracts Service (CAS) number 65169-36-0, is a significant heterocyclic compound that has garnered considerable attention in the field of pharmaceutical and chemical research. This compound belongs to the pyridine family, a class of nitrogen-containing heterocycles that are widely recognized for their diverse biological activities and industrial applications. The structural features of 3,4-Dimethyl-5-nitropyridine, particularly the presence of methyl groups at the 3 and 4 positions and a nitro group at the 5 position, contribute to its unique chemical properties and reactivity, making it a valuable intermediate in synthetic chemistry and a potential candidate for further pharmacological exploration.

The synthesis of 3,4-Dimethyl-5-nitropyridine typically involves multi-step organic reactions, often starting from readily available pyridine derivatives. The introduction of the nitro group at the 5-position is a critical step, often achieved through nitration reactions, which require precise control of reaction conditions to ensure high yield and purity. The methyl groups at the 3 and 4 positions enhance the compound's stability and influence its electronic distribution, making it a versatile building block for more complex molecular architectures.

In recent years, 3,4-Dimethyl-5-nitropyridine has been studied for its potential applications in medicinal chemistry. Its structural motif is reminiscent of several bioactive molecules, suggesting that it may serve as a precursor or scaffold for the development of new drugs. Specifically, the nitro group can be reduced to an amine, introducing a reactive site that can be further functionalized. Additionally, the pyridine ring itself is a common pharmacophore in many therapeutic agents, particularly those targeting neurological and cardiovascular diseases.

One of the most promising areas of research involving 3,4-Dimethyl-5-nitropyridine is its role as an intermediate in the synthesis of kinase inhibitors. Kinases are enzymes that play crucial roles in cell signaling pathways and are frequently implicated in various diseases, including cancer. By modifying the structure of 3,4-Dimethyl-5-nitropyridine, researchers have been able to develop compounds that selectively inhibit specific kinases, thereby potentially treating these diseases more effectively. For instance, derivatives of this compound have shown promise in preclinical studies as inhibitors of tyrosine kinases, which are overactive in many types of cancer.

Another area where 3,4-Dimethyl-5-nitropyridine has shown promise is in the development of antimicrobial agents. The unique electronic properties of this compound make it a good candidate for disrupting bacterial cell wall synthesis or interfering with other essential bacterial processes. Recent studies have demonstrated that certain derivatives of 3,4-Dimethyl-5-nitropyridine exhibit potent activity against Gram-positive bacteria, including those resistant to conventional antibiotics. This finding is particularly significant given the growing crisis of antibiotic resistance worldwide.

The industrial relevance of 3,4-Dimethyl-5-nitropyridine extends beyond pharmaceutical applications. It is also used as a ligand in catalytic processes and as a component in specialty chemicals. Its ability to act as a ligand stems from its ability to coordinate with transition metals, forming complexes that can catalyze various organic transformations. These catalytic systems are widely used in industry for processes such as cross-coupling reactions, which are essential for constructing complex organic molecules.

The environmental impact of producing and using 3,4-Dimethyl-5-nitropyridine is also an area of growing interest. As with many chemical intermediates, the synthesis process must be optimized to minimize waste and reduce energy consumption. Green chemistry principles are increasingly being applied to develop more sustainable methods for producing this compound. For example, solvent-free reactions and catalytic processes that use renewable feedstocks are being explored as alternatives to traditional synthetic routes.

In conclusion,3,4-Dimethyl-5-nitropyridine (CAS No: 65169-36-0) is a multifaceted compound with significant potential in pharmaceutical research and industrial applications. Its unique structural features make it a valuable intermediate for synthesizing bioactive molecules, particularly kinase inhibitors and antimicrobial agents. As research continues to uncover new applications for this compound,3,4-Dimethyl-5-nitropyridine is likely to play an increasingly important role in both academic and industrial settings.

• 5832-44-0(4-methyl-3-nitro-pyridine)
• 57927-98-7(4-Methyl-3,5-dinitropyridine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)